Thursday, September 21, 2023
HomeSample Page

Sample Page Title

 Square Enix will shut down its cell RPG-battle royale motion title Final Fantasy 7: The First Soldier on January 11, 2023. The recreation will finish service simply over a yr since its November 2021 launch.

This comes as Square Enix has been making some reassessments, together with the choice final month to close down service of Babylon’s Fall in February 2023. Ultimately, it appeared that the sport, regardless of  an preliminary 2 million downloads by December 2021, the audiences didn’t stick round.

“After almost a year of jumping around on chocobos, mashing it up in melee battles, and sniping from the rooftops of Midgar Undercity, it is with a heavy heart that we are announcing the end of service for FINAL FANTASY VII THE FIRST SOLDIER…. Despite all our efforts to bring you regular updates with fresh and exciting content, we haven’t been able to deliver the experience that we were hoping to, and that you all deserve, so we have made the extremely tough decision to end service for Final Fantasy 7: The First Soldier,” the group introduced.

With the Final Fantasy 7 IP considered iconic and having seen a quantity of spinoffs and the 2020 Final Fantasy VII: Remake, it isn’t shocking that Square Enix tried to maneuver into the cell area with this new RPG. It simply appears that, finally, it didn’t work out. 

There will proceed to be some updates till the sport shuts down, with scheduled updates set to roll out till that point. However, help for non-English languages will finish as of November 1st, with all textual content in English after that time. After making the announcement, gross sales within the store have been halted and all remaining Shinra cash are usable till the sport ends.

Both Final Fantasy 7: The First Soldier and Babylon’s Fall are set to close down after simply round a yr of stay service. 

Read the announcement over at Final Fantasy 7: The First Soldier.



Please enter your comment!
Please enter your name here

Most Popular

Recent Comments